» Articles » PMID: 35664502

A Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Cell Transplantation: Protocol for a Feasibility and Acceptability Randomized Control Trial

Overview
Date 2022 Jun 6
PMID 35664502
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Insomnia, fatigue, and depression are among the most persistent and distressing concerns for hematologic cancer patients recovering from hematopoietic cell transplantation (HCT). This study will evaluate a novel behavioral intervention, (ReSET), designed to alleviate insomnia, fatigue, and depression by improving rest-activity patterns. Evidence-based behavioral strategies to improve nighttime sleep and increase non-sedentary daytime activity will be combined to optimize 24-h rest-activity patterns.

Methods: The protocol herein evaluates the feasibility and acceptability of ReSET by conducting a pilot randomized controlled trial to compare the intervention with usual care. Adults undergoing HCT will be randomly assigned to ReSET or usual care. The ReSET arm will receive 3 face-to-face sessions and telephone coaching delivered in an individual format tailored to each patient. Patient-reported insomnia, fatigue, and depression will be the primary outcome measures. Actigraphy will be used to objectively quantify rest-activity patterns. Semi-structured interviews will evaluate participant satisfaction with ReSET. The goals are to determine: (1) participant satisfaction with and acceptability of the behavioral techniques; (2) facilitator fidelity and participant uptake of key intervention components; (3) ability to recruit, retain, and collect complete data from participants; (4) participant willingness to be randomized and acceptability of the control condition; and (5) validity and acceptability of the assessment strategy.

Conclusion: The overarching goal is to optimize recovery following HCT with a brief, non-invasive intervention that can be implemented as a part of routine clinical care.

Citing Articles

Biobehavioral mechanisms underlying symptoms in cancer patients with chronic graft-versus-host disease.

Hansen J, Rumble M, Coe C, Juckett M, Foster M, Dickson D Brain Behav Immun. 2024; 123:185-192.

PMID: 39288894 PMC: 11624090. DOI: 10.1016/j.bbi.2024.09.017.

References
1.
Andrykowski M, Bishop M, Hahn E, Cella D, Beaumont J, Brady M . Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation. J Clin Oncol. 2005; 23(3):599-608. DOI: 10.1200/JCO.2005.03.189. View

2.
Littner M, Kushida C, Anderson W, Bailey D, Berry R, Davila D . Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002. Sleep. 2003; 26(3):337-41. DOI: 10.1093/sleep/26.3.337. View

3.
Troiano R, Berrigan D, Dodd K, Masse L, Tilert T, McDowell M . Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc. 2007; 40(1):181-8. DOI: 10.1249/mss.0b013e31815a51b3. View

4.
Espie C, Fleming L, Cassidy J, Samuel L, Taylor L, White C . Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol. 2008; 26(28):4651-8. DOI: 10.1200/JCO.2007.13.9006. View

5.
Hann D, Denniston M, Baker F . Measurement of fatigue in cancer patients: further validation of the Fatigue Symptom Inventory. Qual Life Res. 2001; 9(7):847-54. DOI: 10.1023/a:1008900413113. View